|
|||||
Transplant Statistics: Annual Report
| Table 7.5 |
| Patients and Annual Death Rates Per 1,000 Patient Years at Risk, 1991 to 2000 |
| Recipients with Pancreas Transplants |
| Hospitalized at Tx | Year | ||||||||||
| 1991 | 1992 | 1993 | 1994 | 1995 | 1996 | 1997 | 1998 | 1999 | 2000 | ||
| Total | Patients | 221 | 257 | 321 | 323 | 348 | 441 | 560 | 706 | 933 | 1,129 |
| Deaths | 10 | 11 | 12 | 19 | 12 | 12 | 20 | 33 | 30 | 27 | |
| Rate | 57.1 | 52.6 | 52.2 | 82.3 | 46.5 | 36.3 | 47.9 | 62.7 | 45.6 | 43.7 | |
| Not Hospitalized | Patients | 213 | 246 | 309 | 309 | 337 | 426 | 536 | 667 | 820 | 970 |
| Deaths | 9 | 10 | 11 | 17 | 10 | 12 | 18 | 30 | 29 | 23 | |
| Rate | 53.6 | 49.7 | 49.8 | 76.7 | 40.1 | 37.6 | 44.5 | 59.7 | 48.2 | 40.2 | |
| Hospitalized | Patients | 4 | 7 | 9 | 13 | 9 | 10 | 16 | 15 | 20 | 21 |
| Deaths | * | * | * | 2 | * | 0 | 2 | 0 | 0 | 3 | |
| Rate | * | * | * | 245.4 | * | 0.0 | 195.6 | 0.0 | 0.0 | 314.1 | |
| In Intensive Care | Patients | 4 | 4 | 3 | 1 | 2 | 2 | 2 | 3 | 4 | 3 |
| Deaths | * | * | * | * | * | * | * | * | * | * | |
| Rate | * | * | * | * | * | * | * | * | * | * | |
| Unknown | Patients | - | - | - | - | - | 3 | 6 | 21 | 89 | 135 |
| Deaths | - | - | - | - | - | * | * | 2 | 1 | 1 | |
| Rate | - | - | - | - | - | * | * | 222.8 | 24.7 | 28.9 | |
| Source: OPTN/SRTR Data as of August 1, 2001. |
| The sample includes patients with a new or functioning transplant at any time during the year. The period at risk begins on the later of January 1 or the transplant date and ends on the earlier of December 31, the date of death, or the last date of follow-up. Please see Technical Notes chapter for further details about computation of death rates. |
| (-) = None in category. |
| (*) = Values suppressed due to small N (0 to 9). |
Center-Specific Reports | OPO Reports | National Reports | Data Accuracy | Report Timeline
Home | Who We Are | What We Do | About Transplants | Transplant Statistics | Research Resources | Contact Us | Site Map
SRTR Site designed and maintained by Diamond Bullet Design & URREA.